BR0212143A - Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos - Google Patents

Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos

Info

Publication number
BR0212143A
BR0212143A BR0212143-3A BR0212143A BR0212143A BR 0212143 A BR0212143 A BR 0212143A BR 0212143 A BR0212143 A BR 0212143A BR 0212143 A BR0212143 A BR 0212143A
Authority
BR
Brazil
Prior art keywords
treating
fungal infection
mouthwash composition
preventing bacterial
composition
Prior art date
Application number
BR0212143-3A
Other languages
English (en)
Inventor
Anne Bosy
Julian Geller
Original Assignee
Mintaco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mintaco Inc filed Critical Mintaco Inc
Publication of BR0212143A publication Critical patent/BR0212143A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçãO PARA LAVAGEM BUCAL PARA TRATAMENTO OU PREVENçãO DE INFECçãO POR BACTéRIAS OU FUNGOS". São revelados uma composição de antisséptico bucal, e uso e método relacionados, para o tratamento ou prevenção de infecção por bactérias ou fungos na cavidade oral, a composição de antisséptico bucal compreendendo uma quantidade eficaz de metronidazol e nistatina, junto com um veículo oralmente aceitável.
BR0212143-3A 2001-08-24 2002-08-21 Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos BR0212143A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31430401P 2001-08-24 2001-08-24
PCT/CA2002/001293 WO2003017960A1 (en) 2001-08-24 2002-08-21 Oral rinse for treatment or prevention of bacterial and fungal infection

Publications (1)

Publication Number Publication Date
BR0212143A true BR0212143A (pt) 2004-08-24

Family

ID=23219418

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212143-3A BR0212143A (pt) 2001-08-24 2002-08-21 Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos

Country Status (7)

Country Link
US (1) US20040253193A1 (pt)
EP (1) EP1418880A1 (pt)
JP (1) JP2005504773A (pt)
CN (1) CN1764432A (pt)
BR (1) BR0212143A (pt)
CA (1) CA2458219A1 (pt)
WO (1) WO2003017960A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ530915A (en) * 2004-02-02 2004-08-27 Bernard Charles Sherman Antimicrobial oral rinse solid composition to be dispersed in water prior to use in the oral cavity
US20070231274A1 (en) * 2006-03-28 2007-10-04 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
CN101862344B (zh) * 2008-04-03 2012-10-03 北京世纪博康医药科技有限公司 一种含有制霉素漱口制剂
ITMI20130892A1 (it) * 2013-05-31 2014-12-01 Ver Alit S A S Di Furbini Sparta Co Composizione in forma di colluttorio o gel per uso nel trattamento dell'alitosi permanente umana o animale ad eziologia batterica
US20180140379A1 (en) 2016-11-18 2018-05-24 Cutting Edge Technology Periodontic treatment and method
US20180230519A1 (en) * 2017-02-15 2018-08-16 OraVital Inc. Methods and kits for selecting treatment for oral infections
EP3836947A4 (en) 2018-08-17 2022-04-20 Universidad Andres Bello METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE PREVENTION OF RECURRING INFECTIONS CAUSED BY CLOSTRIDIUM DIFFICILE
CN109044960A (zh) * 2018-11-06 2018-12-21 山西天致药业有限公司 甲硝唑含漱液及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO80363A2 (ro) * 1980-11-08 1983-02-01 Intreprinderea De Antibiotice,Ro Gel vaginal poliactiv
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
IL68027A (en) * 1983-03-03 1986-09-30 Univ Ramot Dental preparation for preventing bacterial adherence to the tooth surface
US4997830A (en) * 1990-02-07 1991-03-05 The Research Foundation Of State University Of New York Pharmaceutical composition for the treatment of periodontitis
US5407663A (en) * 1991-04-11 1995-04-18 Eisen; Drore Method of treating inflammatory conditions of the mouth using steroid containing mouthwash which may contain antifungal agents
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
ES2040633B1 (es) * 1991-12-31 1994-05-16 Fitzig Nie Simon Un procedimiento para la preparacion de una composicion oral antihalitosica.
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
WO1995027472A1 (en) * 1994-04-07 1995-10-19 Richter Jon L Oral rinse and method of treating halitosis
CA2143037C (en) * 1994-05-02 2002-04-30 Atma Chaudhari Alcohol free mouthwash
BR9706301A (pt) * 1997-06-16 1999-07-20 Elisabet Casteluci Formulação química terapêutica para creme dental
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US6132701A (en) * 1998-12-17 2000-10-17 Perez; Narciso C. Method for reducing oral malodor
US6071500A (en) * 1999-01-19 2000-06-06 Thistle; Robert H. Breath spray with tooth decay and halitosis prevention characteristics
US6660306B2 (en) * 2000-10-12 2003-12-09 Mickey L. Peshoff Wound healing compound

Also Published As

Publication number Publication date
WO2003017960A1 (en) 2003-03-06
US20040253193A1 (en) 2004-12-16
CA2458219A1 (en) 2003-03-06
EP1418880A1 (en) 2004-05-19
JP2005504773A (ja) 2005-02-17
CN1764432A (zh) 2006-04-26

Similar Documents

Publication Publication Date Title
DE60230021D1 (de) Systeme zur verabreichung eines kosmetischen und/oder therapeutischen wirkstoffes an mundoberflächen
SE0102315D0 (sv) Compounds
WO2005030186A3 (en) Method for attenuating virulence of microbial pathogens and for inhibiting microbial biofilm formation
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
GB0101577D0 (en) Compounds
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
AU7994594A (en) Plaster for the treatment of nail mycoses
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
BG106366A (en) Moxifloxacin formulation containing common salt
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ATE363267T1 (de) Mittel zur verbesserung der hauttextur
BR0212143A (pt) Composição para lavagem bucal para tratamento ou prevenção de infecção por bactérias ou fungos
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
BR0311874A (pt) Uso de nefopam para o tratamento de náusea ou emese
WO2003009859A1 (en) Immunotherapy for humans
AU2001238332A1 (en) Method of sterilizing articles
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
ATE409499T1 (de) Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
EP4344749A3 (en) Protease formulation for treatment of microbial infections
IT1321290B1 (it) Metodo per la sterilizzazione di condotti di alimentazione di fluidoa strumenti medici, ed in particolare odontoiatrici.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 8/49 (2006.01), A61K 8/60 (2006.01), A61K 31/